Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 6 April 2006. doi:10.1136/thx.2005.053041
Thorax 2006;61:521-527
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
thx.2005.053041v1
61/6/521    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Callister, M E
Right arrow Articles by Evans, T W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Callister, M E
Right arrow Articles by Evans, T W
Topic Collections
Right arrowRelevant Article

ACUTE LUNG INJURY

Extracellular thioredoxin levels are increased in patients with acute lung injury

M E Callister1, A Burke-Gaffney1, G J Quinlan1, A G Nicholson2, R Florio2, H Nakamura3, J Yodoi4, T W Evans1

1 Unit of Critical Care, National Heart and Lung Institute Division, Imperial College Faculty of Medicine, Royal Brompton Hospital, London, UK
2 Department of Histopathology, Royal Brompton Hospital, London, UK
3 Department of Experimental Therapeutics, Translational Research Center, University of Kyoto, Kyoto, Japan
4 Department of Biological Responses, Institute of Virus Research, University of Kyoto, Kyoto, Japan

Correspondence to:
Correspondence to:
Professor T W Evans
Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; T.Evans{at}rbht.nhs.uk

Background: Acute lung injury (ALI) and its extreme manifestation the acute respiratory distress syndrome (ARDS) complicate a wide variety of serious medical and surgical conditions. Thioredoxin is a small ubiquitous thiol protein with redox/inflammation modulatory properties relevant to the pathogenesis of ALI. We therefore investigated whether thioredoxin is raised extracellulary in patients with ALI and whether the extent of any increase is dependent upon the nature of the precipitating insult.

Methods: Bronchoalveolar lavage (BAL) fluid and plasma samples were collected from patients with ALI (n = 30) and healthy controls (n = 18, plasma; n = 14, BAL fluid). Lung tissue was harvested from a separate group of patients and controls (n = 10). Thioredoxin was measured by ELISA in fluids and by immunohistochemistry in tissue. Interleukin (IL)-8 levels were determined by ELISA. Disease severity was assessed as APACHE II and SOFA scores.

Results: BAL fluid levels of thioredoxin were higher in patients with ALI than in controls (median 61.6 ng/ml (IQR 34.9–132.9) v 16.0 ng/ml (IQR 8.9–25.1), p<0.0001); plasma levels were also significantly higher. When compared with controls, sections of wax embedded lung tissue from patients with ALI showed greater positive staining for thioredoxin in alveolar macrophages and type II epithelial cells. BAL fluid levels of thioredoxin correlated with IL-8 levels in BAL fluid but not with severity of illness scores or mortality. BAL fluid levels of thioredoxin, IL-8, and neutrophils were significantly greater in patients with ALI of pulmonary origin.

Conclusions: Extracellular thioredoxin levels are raised in patients with ALI, particularly of pulmonary origin, and have a significant positive association with IL-8. Extracellular thioredoxin levels could provide a useful indication of inflammation in ALI.


Abbreviations: ALI, acute lung injury; ARDS, acute respiratory distress syndrome; BAL, bronchoalveolar lavage; IL, interleukin; Trx, thioredoxin

Keywords: acute lung injury; acute respiratory distress syndrome; interleukin-8; inflammation; thioredoxin


Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2006 61: 459. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Z. Wang, D. Beach, L. Su, R. Zhai, and D. C. Christiani
A Genome-Wide Expression Analysis in Blood Identifies Pre-Elafin as a Biomarker in ARDS
Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 724 - 732.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Hoshino, T. Nakamura, A. Sato, M. Mishima, J. Yodoi, and H. Nakamura
Neurotropin Demonstrates Cytoprotective Effects in Lung Cells through the Induction of Thioredoxin-1
Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kobayashi-Miura, K. Shioji, Y. Hoshino, H. Masutani, H. Nakamura, and J. Yodoi
Oxygen sensing and redox signaling: the role of thioredoxin in embryonic development and cardiac diseases
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2040 - H2050.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S V Baudouin
Manipulation of inflammation in ARDS: achievable goal or distant target?
Thorax, June 1, 2006; 61(6): 464 - 465.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society